CRISPR Therapeutics AG (CRSP)

60.82 +5.62 (+10.17%) USD  |  NASDAQ  |  Feb 26, 15:16
More

CRISPR Therapeutics Repurchase of Capital Stock (Quarterly)

Repurchase of Capital Stock (Quarterly) Chart

View Repurchase of Capital Stock (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Repurchase of Capital Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Repurchase of Capital Stock (Quarterly) Range, Past 5 Years

View Repurchase of Capital Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Repurchase of Capital Stock (Quarterly) Benchmarks

View Repurchase of Capital Stock (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novartis AG Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
EvoNext Holdings SA --